Haiying Zhan, MD, PhD
Assistant Professor of PathologyCards
About
Research
Publications
2026
Lessons Learned From 26 Adenomyoepitheliomas of the Breast.
Colón Cartagena L, Perera N, Liang Y, Zhan H, Krishnamurti U. Lessons Learned From 26 Adenomyoepitheliomas of the Breast. The American Journal Of Surgical Pathology 2026 PMID: 42676113, DOI: 10.1097/pas.0000000000002598.Peer-Reviewed Original ResearchPathologic Characterization of Non-Mass Enhancement Lesions of the Breast in MRI-guided Biopsy
Jordan T, Liang Y, Colón Cartagena L, Buza N, Krishnamurti U, Zhan H. Pathologic Characterization of Non-Mass Enhancement Lesions of the Breast in MRI-guided Biopsy. Human Pathology 2026, 106220. PMID: 42556743, DOI: 10.1016/j.humpath.2026.106220.Peer-Reviewed Original ResearchHistomorphologic analysis and clinical correlation of atypical apocrine lesions in breast pathology
Podany P, Zhan H, Colón-Cartagena L, Ai D, Du J, Krishnamurti U, Liang Y. Histomorphologic analysis and clinical correlation of atypical apocrine lesions in breast pathology. Human Pathology 2026, 175: 106158. PMID: 42176994, DOI: 10.1016/j.humpath.2026.106158.Peer-Reviewed Original ResearchPathological response to herceptin-containing neoadjuvant therapy in HER2 IHC2+/ISH+ and IHC3+ early-stage invasive ductal carcinoma
Jordan T, Chan N, Rimm D, Zhan H. Pathological response to herceptin-containing neoadjuvant therapy in HER2 IHC2+/ISH+ and IHC3+ early-stage invasive ductal carcinoma. Human Pathology 2026, 173: 106121. PMID: 41985721, DOI: 10.1016/j.humpath.2026.106121.Peer-Reviewed Original ResearchAdultAgedAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorBreast NeoplasmsCarcinoma, Ductal, BreastFemaleHumansImmunohistochemistryIn Situ Hybridization, FluorescenceMiddle AgedNeoadjuvant TherapyNeoplasm StagingNeoplasm, ResidualPathologic Complete ResponseRetrospective StudiesTrastuzumabTreatment OutcomeDiagnosis of Ductal Carcinoma in Situ in Breast Biopsies for a Radiological Mass Lesion: Did We Miss Something?
Theriot J, Zhan H, Colón-Cartagena L, Lotfi P, Krishnamurti U, Liang Y. Diagnosis of Ductal Carcinoma in Situ in Breast Biopsies for a Radiological Mass Lesion: Did We Miss Something? International Journal Of Surgical Pathology 2026, 34: 1446-1451. PMID: 41944434, DOI: 10.1177/10668969261436010.Peer-Reviewed Original ResearchClinicopathologic Analyses of 34 Cases of High-Grade Serous-Like Carcinoma (HG-SL-Ca) of the Breast
Haw Y, Krings G, Hsiao W, Zhan H, Hou Y, Zhang G, Zhang H, Wei S, Yang W, Laé M, Post M, Liu Y, Shamir E, Rosa M, Siziopikou K, Schnitt S, Chen Y, Li X. Clinicopathologic Analyses of 34 Cases of High-Grade Serous-Like Carcinoma (HG-SL-Ca) of the Breast. The American Journal Of Surgical Pathology 2026, 50: 543-549. PMID: 41735183, DOI: 10.1097/pas.0000000000002516.Peer-Reviewed Original ResearchQuantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score
He M, Chan N, Liu M, Robbins C, Bates K, Benanto J, Colón-Cartagena L, Kahila M, Zhan H, Krishnamurti U, Moutafi M, Yaghoobi V, Liebler D, Fulton R, Rimm D. Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score. Applied Immunohistochemistry & Molecular Morphology 2026, 34: 143-154. PMID: 41709478, PMCID: PMC13143368, DOI: 10.1097/pai.0000000000001311.Peer-Reviewed Original Research
2025
Mixed Molecular Subtypes Coexist in Estrogen Receptor Heterogeneous Primary Breast Cancers
Foldi J, Xiong K, Liu M, Robbins C, Chen F, Zhan H, Burela S, Dai J, Karn P, Dugo M, Bianchini G, Lee A, Oesterreich S, Rimm D, Pusztai L. Mixed Molecular Subtypes Coexist in Estrogen Receptor Heterogeneous Primary Breast Cancers. JCO Precision Oncology 2025, 9: e2500529. PMID: 41237360, PMCID: PMC13327085, DOI: 10.1200/po-25-00529.Peer-Reviewed Original ResearchInvasive breast carcinoma in a patient with PHTS: a case report
Zhan H, Fischbach N, Lynch M, Liang Y, Krishnamurti U, Cohen P. Invasive breast carcinoma in a patient with PHTS: a case report. Diagnostic Pathology 2025, 20: 120. PMID: 41107919, PMCID: PMC12532417, DOI: 10.1186/s13000-025-01715-1.Peer-Reviewed Original ResearchPredicting the Probability of Residual Axillary Nodal Metastases in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
Khoury T, Zhan H, Huang X, Ghasemi F, Rajack F, Yuan G, Yu H, Theriot J, Bragiel R, Okamoto K, Ali M. Predicting the Probability of Residual Axillary Nodal Metastases in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy. Modern Pathology 2025, 38: 100902. PMID: 41043643, PMCID: PMC12624850, DOI: 10.1016/j.modpat.2025.100902.Peer-Reviewed Original Research
News
News
- September 24, 2026
Study Informs How to Diagnose Underrecognized Breast Tumor
- March 17, 2026
Yale Pathology Will Have Strong Presence at USCAP 2026
- May 05, 2025
Older Women May Benefit From Regular Mammograms